Contract Research Organizations (CROs) play a key role in the development of clinical research due to their number of resources and adaptability. But why have their uptick in the recent decades become so notorious?
Traditionally, pharmaceutical companies would include all phases involved in the research activities in their operations system. The emergence of innovative techniques and work philosophies that help increase competitiveness has created the need to stay up-to-date and increase either the qualification level of their staff and the resources available or outsource some services to specialized companies.
The data of its evolution are impressive: Since year 2,000, pharmaceutical industry began to delegate the activities of protocol design, approval from authorities, field trials, statistical analysis… to new companies. In less than a decade, the know-how of the CRO’s market made their annual growth out of 15%, employ 70,000 people and nearly 10,000 clinical trials had already been conducted.
CRO’s must be able of reach an efficient project management system that will meet the quality requirements and based on clearly defined objectives that will guide the testing development. Each project has its peculiarities and demands, so in Tests&Trials we adapt our working methodology to ensure that the most appropriate steps are taken.
By providing their knowledge and experience, these organizations accomplish the reduction of the development time of the new products by establishing efficient control mechanisms which allow them to act quickly and to implement corrective measures on time.